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Summary
Paget’s Disease of Bone (PDB), first described by James
Paget in 1877, is characterized by rapid bone remodeling and
the formation of bone that is structurally abnormal. The aetiol-
ogy is unknown, although both genetic and environmental
factors have been implicated. PDB is more prevalent among
men than women, and prevalence increases progressively
with age, reaching around 15% in elderly men in Britain. In
this article, we review the patterns of occurrence of Paget’s
disease according to age, gender, ethnic group, and geo-
graphical location. We also discuss recent work documenting
mortality rates and secular trends for the disorder over the
last two decades, and discuss the aetiological implications of
the epidemiological data.
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Introduction
James Paget originally described “osteitis deformans” in an el-
derly man with progressive skeletal deformities in 1877 (1).
The condition subsequently became known as Paget’s Disease
of Bone (PDB), and is characterized by rapid bone remodeling
and the formation of bone that is structurally abnormal. The ae-
tiology is unknown, although both genetic and environmental
factors have been implicated. Postmortem and radiographic
series have confirmed that the disease is more prevalent
among men than women, and that prevalence increases pro-
gressively with age, reaching around 15% in elderly men in
Britain (2, 3). In this article, we review the patterns of occur-
rence of Paget’s disease according to age, gender, ethnic
group, and geographical location. Moreover, we discuss recent
work documenting mortality rates and secular trends for the
disorder over the last two decades, and discuss the aetiological
implications of the epidemiological data.
Prevalence of Paget’s disease by age and gender
The most comprehensive available data on the prevalence of
Paget’s disease by age and gender were provided from sur-
veys of abdominal radiographs from stored films within a group
of British hospitals, conducted during 1970-1977 (4, 5). As part
of these studies, around 30,000 radiographs of men and
women aged ‡ 55 years were evaluated in 31 towns through-
out the Country. In each town, samples were taken from the
stored films within X-ray Departments of the Serving General
Hospitals. The selected films showed the entire pelvis and
sacrum, both femoral heads, and all lumbar vertebrae. Ninety
five percent of patients with Paget’s disease demonstrate radi-
ographic abnormalities of the disorder at one of these sites (5).
The films included those taken specifically to show the skele-
ton, as well as those taken during intravenous pyelography,
barium studies, and plain abdominal radiographs. Samples of
about 1000 radiographs were drawn for each of the towns
studied (500 male and 500 female). 
The films were initially classified by a trained observer into
three groups: positive (unequivocal signs of Paget’s disease);
doubtful; and negative. A second observer (a consultant radiol-
ogist) then examined all the positive and doubtful films and a
one in ten sample of the negative ones. The doubtful group
made up about 3-4% of the total films examined, and all were
subsequently classified as either positive or negative. Stan-
dardized criteria for the radiological diagnosis of Paget’s dis-
ease (Table I) were established in a pilot study and were de-
rived from those of Murray and Jacobson (6) and Campbell-
Goulding (7). Figure 1 shows the prevalence of radiographical-
ly apparent Paget’s disease according to age and gender in
this study. The overall prevalence of the disorder was 5% (men
6.2%, women 3.9% after age and gender standardization).
There was a steep increase in the frequency of Paget’s dis-
ease with advancing age in both genders. Thus, prevalence
rose from around 2% in men aged 55-59 years to 20% in those
aged 85+ years; in women of comparable ages, the prevalence
rose from 1% to around 7%.
Geographic variation in prevalence
Prevalence in Britain
This large British survey (4), performed 20 years ago, revealed
marked geographic variation in prevalence within the Country.
Age/gender-standardized prevalence rates above 6%, were
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Table I - Radiographic criteria for the diagnosis of Paget’s disease.
– Increase in bone density/areas of increased lucency
– Increase in bone size
– Bone deformity
– Cortical thinning
– Enhanced trabecular pattern
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only found in a cluster of six Lancashire towns: Lancaster
(8.3%); Preston (7.5%); Bolton (7.1%); Wigan (6.8%); Burnley
(6.5%); and Blackburn (6.3%). Outside this small area of high
prevalence, the rates fell sharply, with the bordering towns
having rates of around the average for all other towns. This
striking geographic variation is illustrated in Figure 2. It was ap-
parent for subjects undergoing radiography for skeletal and
non-skeletal indications.
Prevalence in Europe
Extension of this radiographic survey to Western Europe (8),
revealed that rates in Britain were substantially higher than for
most other countries of Western Europe. Outside Britain, the
highest prevalences (2.0% to 2.7%) were found in three French
towns (Bordeaux, Rennes, and Nancy). These prevalences
were lower than the overall prevalence of 4.6% in Britain, but
were comparable with the lowest values recorded in individual
British towns (2.7% in Carlisle and 2.3% in Aberdeen). In the
remaining European towns, the prevalence rates ranged from
1.7% in Dublin (Ireland) and 1.3% in Valencia (Spain), to 0.5%
in Palermo (Italy) and 0.4% in Malmö (Sweden). This geo-
graphic variation was concordant with a questionnaire survey
of radiologists in these countries of Western Europe, which en-
quired about the frequency with which Paget’s disease was
seen as either the principal abnormality, or as an incidental ab-
normality, on radiographs. 
However, in a more recent case control study, nested within
the Rotterdam Study (The Netherlands), a higher overall preva-
lence of 3.6% was ascertained (9). The Rotterdam Study is a
well-characterized cohort of 7983 men and women ³  55 years
old, recruited in the early 1990s for the study of chronic dis-
eases. Those subjects with a raised serum alkaline phos-
phatase were matched with controls, and radiographs of the
hands, thoracolumbar spine, pelvis and knees were taken. The
relative risk of PDB in subjects with a raised alkaline phos-
phatase was 10.9 (95% CI, 4.8-24.9). When diagnoses of PDB
based on radiographic localizations not included in previous
studies were excluded, the prevalence dropped to 2.4%. The
only previous study in The Netherlands was a small hospital
based survey of abdominal radiographs, which found a preva-
lence of 0.6%. This may reflect differences in the populations
studied (community vs hospital), and the small numbers includ-
ed in the earlier study.
Prevalence in North America, Australia, and New Zealand
Within the USA, comparison of a northern city, New York, with
a southern city, Atlanta, revealed a marked difference in preva-
lence rates, with a rate of 3.9% in New York and only 0.9% in
Atlanta (10). Markedly lower rates in the southern city were al-
so seen among blacks than whites. This accords with the ob-
servation that Paget’s disease is rare in Africa. It also parallels
findings in Perth, Australia (11), where the prevalence among
British-born immigrants (4%) was intermediate between the
British rate (5%) and that among native-born Australians
(3.2%) (Table II). These two sets of observations among com-
munities that have migrated point strongly to the influence of
environment in the etiology of the disease.
Table II - Migrant studies of Paget’s disease (11).
Birth Prevalence (%)*
Residence Men Women All
Australia Australia 3.5 2.8 3.2
UK Australia 5.7 2.3 4.0
UK UK 6.2 3.9 5.0
* Prevalence adjusted for age.
Incidence by age and gender in Britain
The General Practice Research Database (GPRD) contains
computerized patient records from 683 GP practices in Eng-
land and Wales, covering 6% of the registered population. In-
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Figure 1 - Prevalence of PDB in England and Wales, by age and sex,
based on a radiographic survey performed in 1974 (5).
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Figure 2 - Age- and sex-standardised prevalence rate (%) of PDB
among men and women aged ³  55 years in 31 British towns surveyed
in 1974 (4).
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formation recorded in the database includes diagnosis and
treatment. The dataset was used in a retrospective cohort
study to assess the incidence of PDB over the period 1988 to
1999 (12): 2465 patients with PDB were identified after exclu-
sion of those with Paget’s disease of the breast, out of the 5
million subjects ³ 18 years old. The validity of diagnostic
recording was assessed by questionnaire to individual gener-
al practitioners (GPs) in 150 patients; the diagnosis was con-
firmed in 93.8% of responders. The mean age of patients with
Paget’s disease was 75 years and 51% were men. Incidence
rates for clinically diagnosed Paget’s disease rose steeply
with age  thus the rate was 0.3 per 10,000 person-years for
women aged 55-59 years, rising to 5.4 per 10,000 person
years at age ³  85 years. The corresponding figures for men
were 0.5 and 7.6 per 10,000 person-years respectively. Fig-
ure 3 shows the influence of age on incidence on PDB in men
and women.
Morbidity and mortality
PDB is associated with increased morbidity through bone pain,
fracture, deafness and increased risk of osteoarthritic change
in an adjacent joint, and malignant change to an osteosarco-
ma. The GPRD study (12) explored these factors by comparing
subjects with PDB to three controls matched by age, gender,
and general practice. Cases had a greater risk of back pain
(relative risk [RR], 2.1; 95% CI, 1.9-2.3), osteoarthritis (RR, 1.7;
95% CI, 1.5-1.9), hip arthroplasty (RR, 3.1; 95% CI, 2.4-4.1),
knee arthroplasty (RR, 1.6; 95% CI, 1.0-2.6), fracture (RR, 1.2;
95% CI, 1.0-1.5), and hearing loss (RR, 1.6; 95% CI, 1.3-1.9).
Seven patients with Paget’s disease developed a malignant
bone neoplasm (0.3%). Using life table methodology, the esti-
mated number of people who died within 5 years of follow-up
was 32.7% among the patients with Paget’s disease, and
28.0% among the control patients. Figure 4 shows the Kaplan-
Meier survival plot for subjects and controls over time.
Time trends in mortality, prevalence, and severity
There is much circumstantial evidence pointing to a decline in
the frequency of Paget’s disease in recent years. Table III re-
veals mortality rates attributable to (a) Paget’s disease and (b)
malignant tumors of bone between 1951 and 1970. Through-
out Great Britain there has been a gradual decline in mortality
from both causes over the 20 year period studied (13,14). Fur-
thermore, when mortality is analyzed in relation to year of
birth, successive British birth cohorts have had progressively
lower death rates from Paget’s disease; the highest death
rates have been observed in cohorts born during the 1880s,
with progressively lower rates thereafter. Analyses of mortality
from Paget’s disease among whites in the USA appear to
show a similar pattern of decline, although death rates in the
USA are somewhat lower. Recent data on temporal trends in
the prevalence of Paget’s disease have emerged from a fol-
low-up prevalence survey in ten British towns during 1993-
1995 (15), utilizing identical methods to those of the original
surveys of 1970-1977. The results of this follow-up study sug-
gest that the age/gender-standardized prevalence of Paget’s
disease has fallen sharply between 1974 and 1994. Indeed
the overall prevalence in the follow-up was 40% of that in the
i itial study. The overall age-adjusted prevalence rate in the
ten towns in 1994 was 2.5% (95% CI, 2.1%-3.0%) for men
and 1.6% (95% CI, 1.3-1.9) for women, compared with 6.2%
and 3.9% respectively observed during 1974. The prevalence
rate had decreased among both men and women, and was
most marked in those towns with the highest prevalence in the
original study. 
Other clinical surveys also point to a decrease in the preva-
lence and severity of Paget’s disease. The GPRD study (12)
was able to observe changes in incidence over the period
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Figure 3 - Age- and sex-specific incidence rate of PDB among 5 million
men and women registered on the GPRD (1988-1999) (12).
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Figure 4 - Survival over 5 years after clinical diagnosis among 2465 pa-
tients with PDB and 7395 controls registered in the GPRD (12).
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1988 to 1999. Over the 11-year period of the study, the age-
and sex-adjusted incidence rate of clinically diagnosed
Paget’s disease declined from 1.1 per 10,000 person-years to
0.7 per 10,000 person-years (Figure 5). Additionally, observa-
tion of temporal trends in the radiographic and biochemical
severity of Paget’s disease at diagnosis in a New Zealand
hospital service (16) suggests a progressive decline in both
serum alkaline phosphatase and scintigraphic grade at pre-
sentation, between 1973 and 1993. These data suggest that
both the prevalence and severity of the disorder have been
declining in recent years.
Table III - Mortality rates from PDB and malignant tumours of bone
among men and women aged ³  55 years in UK (1951-1970) (14).
Annual mortality rate England / Wales Scotland
(per 106)
Paget’s disease
1951-55 13.7 12.9
1956-60 13.6 12.4
1961-65 13.4 12.2
1966-70 13.2 11.4
Malignant tumours of bone
1951-55 48.2 82.4
1956-60 39.7 57.6
1961-65 32.6 41.2
1966-70 28.2 33.7
A tiology
These epidemiological observations have implications for our
understanding of aetiology of PDB. A strong familial aggregation
h s been observed for PDB, and recent molecular studies have
proposed genetic markers for susceptibility among affected
members of multicase families. However, in one study only 4-5%
of patients with PDB had a strong family history (17), and it
seems unlikely that an exclusively genetic predisposition will ac-
count for a large proportion of PDB in the general population.
Other investigators have suggested an infectious etiology for
PDB. Focus has been directed at the role of viral infection, but
attempts to identify a specific causative agent have yielded in-
consistent results. 
The dramatic decline in the prevalence of Paget’s disease,
coupled with the marked geographic variations and cohort ef-
fects in mortality, strongly support an environmental contribu-
tion to its etiology. Recent work, using 202 subjects in the
New England Registry for Paget’s Disease of Bone (18),
found that those cases with a positive family history of PDB
had an earlier age of onset (51 years vs 59 years, p < 0.05),
and trend to a higher incidence of bone deformity (49% vs
33%, p < 0.1), and an increased fracture rate (27% vs 11%, p
< 0.05). Environmental factors were further explored, and the
Authors found that a history of measles infection, childhood
exposure to pets, milk ingestion, year of immigration to the
USA, birth order, level of education, and functional status,
were not significantly differentiate between those with a fami-
ly history of PDB and those without. Interestingly, in this co-
hort, the proportion of patients with a positive family history
was 20%, but, as families share environmental as well as ge-
netic factors, this figure does not reflect the purely genetic
component of aetiology. 
Conclusions
Descriptive epidemiological studies suggest that Paget’s dis-
ease shows an increasing frequency of occurrence with age in
Western populations, and is more frequent among men than
women. There is marked geographic variation in the preva-
lence of disease throughout Western Nations, with the highest
rates reported during the 1970s in Britain. Heterogeneity in
prevalence is also found within Britain, with foci of high rates in
the Northwestern region of the Country. Recent studies of the
secular trends in Paget’s disease suggest declining rates in
both prevalence and severity at diagnosis. The epidemiological
data suggest a substantial environmental role in the aetiology
of PDB, in addition to a genetic component. Further studies
should be directed at characterizing the nature of environmen-
tal risk factors and exploring the means whereby genetic and
environmental risk factors might interact.
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